Artelo Biosciences Stock Forecast for 2023 - 2025 - 2030
Updated on 04/19/2024
Artelo Biosciences Stock Forecast and Price Target
The average price target of $5.00 for Artelo Biosciences's stock set by distinguished analysts in recent weeks would represent a potential upside of approximately 199.4% from the last closing price in February, 2024 if reached by the end of the year. This potential increase is based on a high estimate of $40.00 and a low estimate of $5.00. Even if you're not interested in ARTL stock, you may be interested in its competitors.
199.40% Upside
Artelo Biosciences Fair Value Forecast for 2023 - 2025 - 2030
In the last zero years, Price for Artelo Biosciences has grown by 100.00%, going from $0.00 to $0.00. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach $1.80 – an increase of 100.00%. Over the next seven years, experts anticipate that Fair Value growth for Artelo Biosciences will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LLY Stock Forecast | Eli Lilly and | Outperform |
16
|
$745.95 | Buy/Sell | $636.99 | 12.27% |
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$145.74 | Buy/Sell | $174.55 | 16.65% |
| MRK Stock Forecast | Merck | Outperform |
2
|
$125.23 | Buy/Sell | $130.51 | 11.00% |
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$25.39 | Buy/Sell | $32.87 | 20.13% |
| VRTX Stock Forecast | Vertex Pharmaceuticals Inc | Outperform |
12
|
$393.48 | Buy/Sell | $457.59 | 14.36% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$48.30 | Buy/Sell | $58.15 | 13.87% |
| REGN Stock Forecast | Regeneron Pharmaceuticals | Outperform |
2
|
$893.99 | Buy/Sell | $961.26 | 17.45% |
| ZTS Stock Forecast | Zoetis | Outperform |
18
|
$153.11 | Buy/Sell | $220.47 | 44.67% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAX Stock Forecast | Baxter International Inc | Outperform |
17
|
$39.65 | Buy/Sell | $44.86 | 13.49% |
| ALNY Stock Forecast | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$145.16 | Buy/Sell | $245.24 | 48.11% |
| VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.12 | Buy/Sell | $11.73 | 7.91% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| UTHR Stock Forecast | United Therapeutics | Outperform |
12
|
$236.93 | Buy/Sell | $284.08 | 25.35% |
| CTLT Stock Forecast | Catalent | Hold |
15
|
$55.80 | Buy/Sell | $49.29 | 13.80% |
| CYTK Stock Forecast | Cytokinetics | Outperform |
10
|
$67.00 | Buy/Sell | $87.92 | 40.30% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IONS Stock Forecast | Ionis Pharmaceuticals | Outperform |
9
|
$40.81 | Buy/Sell | $55.60 | 47.51% |
| MDGL Stock Forecast | Madrigal Pharmaceuticals | Outperform |
4
|
$222.26 | Buy/Sell | $315.92 | 75.47% |
| BCPC Stock Forecast | Balchem | Outperform |
18
|
$143.12 | Buy/Sell | $145.00 | 13.89% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PRGO Stock Forecast | Perrigo Co PLC | Outperform |
16
|
$29.94 | Buy/Sell | $44.75 | 33.60% |
| NEOG Stock Forecast | Neogen | Outperform |
16
|
$11.93 | Buy/Sell | $37.00 | 42.50% |
| AMPH Stock Forecast | Amphastar Pharmaceuticals | Outperform |
14
|
$38.65 | Buy/Sell | $69.00 | 60.41% |
Artelo Biosciences EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last zero years, EPS for Artelo Biosciences has grown by 100.00%, going from $0.00 to $0.00. In the coming year, analysts are expecting an increase in EPS, predicting it will reach $-1.08 – an increase of 100.00%. Over the next seven years, experts anticipate that EPS growth for Artelo Biosciences will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TGTX Stock Forecast | TG Therapeutics | Outperform |
9
|
$13.99 | Buy/Sell | $29.44 | 143.03% |
| CORT Stock Forecast | Corcept Therapeutics | Buy |
16
|
$22.66 | Buy/Sell | $35.67 | 67.70% |
| INDV Stock Forecast | Indivior PLC | Buy |
14
|
£15.24 | Buy/Sell | £28.89 | 106.69% |
.jpg)